Open AccessAssociation of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications
Jama PsychiatryPeer ReviewedIslam R. Younis +62020Journals
Facilitating the development of safe and effective medications for schizophrenia is a public health imperative.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support